BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2300478, MYC, Metabolism of xenobiotics, Diabetes mellitus, Stem cell, Nosology)
Bookmark Forward

QuickView for STEAP;jsessionid=3820554E5CC1FFE16E0469455680361E;jsessionid=76AFCCA525ACDE70C7413C2CAD045FB9 (gene)


Body Atlas

Most Correlated Tissues

  1. Prostate gland
  2. Pericardium
  3. Peritoneum
  4. Colon mucosa
  5. Adipose tissue subcutaneous
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Preterm premature rupture of membranes
  2. Microbial culture finding
  3. Hypervolemia
  4. Musculoskeletal finding
  5. Liver transplant disorder
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CP 724714
  2. AZD8055
  3. Apitolisib
  4. 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one
  5. YM 201636
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. GRWD1
  2. RIOK2
  3. LEF1
  4. RPS6
  5. BRDT
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Inhibition of STEAP1 ameliorates inflammation and ferroptosis of acute lung injury caused by sepsis …
  2. Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune response…
  3. Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates fo…
  4. The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis…
  5. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for STEAP;jsessionid=3820554E5CC1FFE16E0469455680361E;jsessionid=76AFCCA525ACDE70C7413C2CAD045FB9
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.